The financials
AdaptHealth Corp. by the numbers
AdaptHealth Corp. (AHCO) reported revenue of $820M in Q1 2026 (quarter ended March 31, 2026), up 5.4% from the same quarter a year earlier. That came with a gross margin of 14% and net loss of $16M. For the full year FY2025, revenue was $3.24B (−0.5% year on year) and net income −$71M. Its largest product in 2024-Q3 was Health Care Sleep Therapy Equipment Supplies And Related Services at $238M, 47% of the disclosed total, just ahead of Diabetes at 27%.
| Income statement | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $820M | $778M | +5.4% |
| Gross profit | $112M | $120M | −7.4% |
| Operating income | $5.5M | $23M | −76% |
| Net income | −$16M | −$7.2M | n/a |
| Diluted EPS | −$0.12 | −$0.05 | n/a |
| Product | Revenue | Share |
|---|---|---|
| Health Care Sleep Therapy Equipment Supplies And Related Services | $238M | 47% |
| Diabetes | $137M | 27% |
| Health Care Other | $60M | 12% |
| Supplies To Home | $44M | 8.5% |
| Health Care Home Medical Equipment | $24M | 4.8% |
| Health Care Respiratory Services | $8.1M | 1.6% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q3 2024Total $510.7M (-1.1%)
Health Care Sleep Therapy Equipment Supplies And Related Services grew +4.6% year on yearDiabetes -13% year on year
Segment Latestquarter on quarteryear on year
- Health Care Sleep Therapy Equipment Supplies And Related Services$237.5M$237.5MQoQ +1.8%year on year +4.6%+1.8%+4.6%
- Diabetes$137.1M$137.1MQoQ -6.9%year on year -13%-6.9%-13%
- Health Care Other$60.0M$60.0MQoQ +4.1%year on year -6.5%+4.1%-6.5%
- Supplies To Home$43.5M$43.5MQoQ -1.7%year on year -10.0%-1.7%-10.0%
- Health Care Home Medical Equipment$24.3M$24.3MQoQ -6.3%year on year -10%-6.3%-10%
- Health Care Respiratory Services$8.1M$8.1MQoQ +3.5%year on year -0.20%+3.5%-0.20%